# Tacrolimus for Malar Edema

> **NCT03715387** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 100 (estimated)

## Conditions studied

- Edema Face

## Interventions

- **DRUG:** Tacrolimus Topical 0.1% Topical Ointment
- **DRUG:** Polysporin Ointment

## Key facts

- **NCT ID:** NCT03715387
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-10
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03715387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03715387, "Tacrolimus for Malar Edema". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03715387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*